OrganiGram Holdings Inc.

TSX:OGI.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.96 -1.43%

-$0.02 today

Market cap
$135.37M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $1.37High $3.09

Volume 0.54M

Average 0.19M

OGI.TO Common Stock Issued

Cash raised by issuing new shares.

OrganiGram Holdings Inc.TSX: OGI.TO

Common Stock Issued · Q2 FY2026 · quarter ended Mar 2026

Common stock issued turns negative

Q2 FY2026 common stock issued was -CA$51K, compared with CA$41.18M a year earlier. Trailing-twelve-month common stock issued was -CA$41K.

Context

  • Common stock issued amounted to 15.9% of revenue in FY2025, down 52.0 pp from a year earlier.
  • Common stock issued increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly common stock issued holds near -CA$51K or moves back toward the trailing-twelve-month quarterly average of -CA$10.25K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-CA$51K-950.0% QoQ
Last fiscal yearSep 2025
CA$41.18M-62.1% YoY
LTMMar 2026
-CA$41K-100.0% YoY
Common Stock Issued past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.1%——
1 year-62.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Issued history

CAD · from the cash flow

Latest · FY2025
41.18M CAD
Year-over-year change
-62.1%
4-year CAGR
-38.3%

Common Stock Issued vs competitors

How OGI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -100.0% is the lowest of 4, against a peer median of +39.1%.
  • Common stock issued amounts to 0.0% of revenue for OGI.TO, versus a peer median of 0.3%.
OGI.TO Competitors
Common Stock Issued for OGI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$470.19M CAD+22.0%+609.2%151.2%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$122.24M USD+276.2%+93.8%—
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$44.14M USD——86.3%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$2.39M CAD+39.1%-50.3%1.5%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$587K CAD——0.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$165.63K USD——0.3%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$41K CAD-100.0%—0.0%
DR.TOMedical Facilities CorporationLTM Mar 2026$0 USD——0.0%
TSND.TOTerrAscend Corp.LTM Mar 2026$0 USD——0.0%
HLS.TOHLS Therapeutics Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding OGI.TO) —+39.1%+93.8%0.3%

Competitors are the stored peer set for OGI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(24.76M)
Depreciation & Amortization31.03M24.91M24.17M12.08M17.98M
Deferred Income Tax42.21M(88K)(3.62M)0(13.77M)
Stock-Based Compensation3.9M5.13M5.29M7.18M4.22M
Change in Working Capital24.2M(22.88M)12.51M14.96M(2.12M)
Accounts Receivables(6.01M)(24.02M)12.51M(12.06M)(15.29M)
Inventory28.68M(12.22M)000
Accounts Payables2.06M12.15M000
Other Working Capital(542K)1.21M(5.52M)27.02M13.16M
Other Non-Cash Items776K(29M)155.33M15.09M12.47M
Operating Cash Flow(28.59M)(36.21M)(35.8M)3.87M(7.59M)
Capital Expenditures(12.33M)(48.78M)(26.9M)(5.34M)(17.05M)
Acquisitions (Net)(2.54M)(11.06M)1.03M257K(65.62M)
Purchases of Investments(120.02M)(15M)(10M)(29.24M)(1.01M)
Sales of Investments50.85M114.59M49.4M3.52M2.5M
Other Investing Activities(31.08M)4.29M(8.65M)(7.97M)(1.52M)
Investing Cash Flow(115.11M)44.03M1.36M(38.77M)(82.67M)
Debt Repayment(116.4M)(1.01M)(87K)(786K)(60K)
Common Stock Issued284.88M6.34M20K108.56M41.18M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities5.99M6.34M(750K)6K(1.79M)
Financing Cash Flow174.46M5.33M(817K)107.78M39.33M
Effect of Forex Changes0000313K
Net Change in Cash30.77M13.15M(34.65M)72.88M(49.01M)
Free Cash Flow(40.92M)(84.99M)(62.7M)(1.47M)(24.64M)

OrganiGram Holdings Inc.

TSX:OGI.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.96

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.